
Headlines
ASL Strategic Value Fund targets Avadel board over Lumryz drug mismanagement, WSJ reports
(Reuters) -ASL Strategic Value Fund plans to push shareholders of drugmaker Avadel Pharmaceuticals t...
30th June, 2025

(Reuters) -ASL Strategic Value Fund plans to push shareholders of drugmaker Avadel Pharmaceuticals t...
30th June, 2025

IRVING, Texas, June 04, 2019 — Reata Pharmaceuticals, Inc. (Nasdaq: RETA), a clinical-s...
4th June, 2019